-
-
-
-
-
-
-
STAAR Surgical Announces Participation in Upcoming Investor Conferences
-
-
-
-
-
-
-
STAAR Surgical Announces Preliminary Net Sales for First Quarter 2026
-
-
-
-
-
-
-
Defender Capital opposes STAAR Surgical sale to Alcon ahead of vote
-
-
-
-
-
-
-
Alcon raises STAAR acquisition price to $30.75 per share
-
-
-
-
-
-
-
Yunqi Capital urges STAAR shareholders to reject Alcon merger after Q3 results
-
-
-
-
-
-
-
Yunqi Capital issues new letter to STAAR Surgical (STAA) Board
-
-
-
-
-
-
-
Broadwood Partners: All Three Leading Proxy Advisory Firms Recommend STAAR Surgical Shareholders Vote “AGAINST” Sale to Alcon
-
1,222,379 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

